Baltimore Orioles starting pitcher Kyle Bradish locked down a five-year, $90 million contract extension on Saturday, a deal that officially keeps him under contract through the 2031 season. This massive pact, first reported by ESPN’s Jeff Passan, is a bold move, especially considering Bradish’s recent history coming back from injury.
A Price Tag for Promise and Perseverance
This isn’t just a simple extension, folks. This is the Orioles betting big on Bradish, paying a hefty sum to secure one of their own for the long haul. The $90 million covers his upcoming arbitration years in 2027 and 2028, but then adds three more seasons beyond that. That’s a significant investment, showing the club’s confidence in the 29-year-old righty. Team owner David Rubenstein made it clear, stating, “Keeping players of Kyle’s caliber in an Orioles uniform is an important part of our long-term vision.” He also expressed gratitude for Kyle’s commitment and thanked Mike Elias and the baseball operations department. When an owner steps out to talk about “long-term vision,” it tells you everything about how critical this deal is for their future rotation. This move places Bradish squarely as a core piece for Baltimore, right alongside other recent extensions for pitcher Shane Baz and catcher/designated hitter Samuel Basallo.
The Road Back From the Brink
The “massive bet” part of this deal comes when you look at Bradish’s recent past. He’s had a solid 2026 campaign so far, posting a 6-9 record in 19 starts with a respectable 3.61 ERA, a 1.35 WHIP, and 106 strikeouts across 107.1 innings pitched. Those are good numbers, no doubt. But you have to remember, this dude needed Tommy John surgery in June 2024. That cut his 2024 season short after only eight starts. And his return wasn’t immediate, with Bradish not making it back to the mound until August 2025, where he only managed six starts that season. It was a serious setback, especially after his lights-out 2023 season where he went 12-7 with a fantastic 2.83 ERA, 1.04 WHIP, and 168 strikeouts in 168.2 innings. Back then, he looked like one of MLB’s most promising starting pitchers. The Orioles are essentially paying for him to get back to that 2023 form, and his 2026 numbers are definitely a step in the right direction.
This deal makes it clear that the Orioles are all in on Bradish. They saw the promise, endured the injury, and now they’re backing his bounce-back. With this long-term deal locked down, every start he makes from here on out will be under the microscope. Can he consistently deliver the kind of performance that made him one of baseball’s rising stars before the surgery? The Orioles are banking $90 million on it.
This article was created with AI assistance and published under Seattle On Tap’s editorial standards. See our Editorial Policy.
Leave a Reply